C[C@@H]1OC(=O)C[C@H]2CC(=O)N(CCc3cn(S(=O)(=O)C(F)(F)F)c4ccccc34)C[C@H]12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?